CGA M-2

Original price was: $152.00.Current price is: $76.00.

Standard for the Manufacture of Medical Gases Classified as Drugs

Compressed Gas Association , 06/29/2021

Preview

Category:

This publication applies to firms that engage in the filling, repackaging, transfilling, mixing, and/or re-labeling of CMG classified as drugs by the FDA and applicable state agencies. Although it is primarily intended for firms engaged in the CMG manufacturing processes, portions may apply to firms that only distribute CMG classified as drugs.

This publication is intended to address current good manufacturing practice (CGMP) requirements for:

  • designated medical gases as defined in Section 575(1) of the Federal Food Drug and Cosmetic Act (Act) or combinations thereof; and
  • other medical gases as defined in Section 575(2) of the Act that may be approved via a new drug application (NDA) or abbreviated new drug application (ANDA) for which the sponsor has shown through a science based risk management plan that this publication provides appropriate CGMPs.

Throughout this standard, the terms CMG, medical gas or medical gases are used to refer to these categories of products.

This publication does not apply to:

  • bulk air separation (oxygen, USP and nitrogen, NF) manufacturing and distribution facilities;
  • bulk carbon dioxide USP manufacturing and distribution facilities;
  • bulk helium USP manufacturing and distribution facilities;
  • bulk nitrous oxide USP manufacturing and distribution facilities;
  • refrigerated liquid oxygen USP that is filled at a patient’s residence or is filled, repackaged, transfilled, and/or relabeled by home respiratory care companies;
  • medical gases classified by FDA as medical devices as defined by the Act; or
  • drugs that are defined as Investigational New Drug Applications, e.g., a gas or gas mixture that has never been previously used as a drug, NDAs, or ANDAs by the Act.

NOTE—For information about bulk medical gases classified as drugs, See CGA M-3, Standard for the Manufacturer of Bulk Medical Gases.

See the United States Pharmacopeia and National Formulary (USP–NF) for information on the USP and NF designations for medical gases.

NOTE—Gases such as, diving gases, U.S. Occupational Safety and Health Administration (OSHA) regulated breathing air, aviator’s breathing oxygen, although inhaled are not medical gases.

Original price was: $111.00.Current price is: $55.00.

General Guide for the Manufacturer of Medical Gases Classified as Drugs

Compressed Gas Association , 01/01/2013

Preview

Category:
This publication applies to firms that engage in the filling, repackaging, transfilling, mixing, and/or re-labeling of compressed medical gases (CMG) classified as drugs by the FDA and applicable state agencies. Although it is primarily intended for firms engaged in the CMG manufacturing processes, portions may apply to firms that only distribute CMG classified as drugs.

Original price was: $115.70.Current price is: $57.00.

General Guide for the Manufacturer of Medical Gases Classified as Drugs

Compressed Gas Association , 12/13/2006

Category:
This publication applies to firms that engage in the filling, repackaging, transfilling, mixing, and/or relabeling of compressed medical gases (CMG) that are classified as drugs by the U.S. Food and Drug Administration (FDA) and applicable state agencies. It describes the minimum requirements for manufacturing CMG and is intended to aid the manufacturer in complying with the applicable regulations of the FDA and various state agencies, e.g., departments of health and boards of pharmacy. It contains the information that should be addressed in a firm’s standard operating procedures (SOP). It may not contain the information necessary to comply with all federal and state regulations, so it should be used in conjunction with other compliance publications and guidelines.